Pump Fuse on YaFarm Technologies, Inc. (PINK:YFRM) Getting Short
Pumpers refuse to let go of YaFarm Technologies, Inc. (PINK:YFRM) but it’s no wonder when they expect to pocket $100 thousand for their promotional efforts. Last night a new round of emails was dished out, advertising YFRM stock.
The promo campaign is run by various promoters who come and go, with Market Bulls consistently cropping up. The promotions were the factor which got YFRM trading in the first place, as the stock had flatlined over the previous months. Once the pumps were rolled out on February 5, YFRM sprang into action, closing over 150% in a single day. The pumps onset coincided with a press release from the company, touting YFRM‘s ‘definitive agreement’ to acquire an entity named the Integrative Stem Cell Institute.
YFRM is presented as a stem cell company in the email touts but it was not one until very recently. Up to Q4 of 2012, the company’s line of work was web development. After management and board were switched up around mid-December, the company turned its sights onto medical science. YFRM is keeping a rapid-fire stream of press releases, mostly hyping its purported joint work with the Institute. The newest announcement is focused on more optimistic promises and forward looking statements about a submission for approval of treatment protocols of the Institute by international regulatory stem cell organizations.
The company is generating a lot of buzz but, being a pink sheet, doesn’t seem to think it’s necessary to update traders with actual filings reflecting the PR hype. The latest filings available are dated before the December change of control. The last available financial report of YFRM is for the period ended September 30 and contains the following numbers:
- ZERO revenues
- ZERO in total operating and running expenses
- $1 thousand in cash (total assets)
Those numbers make YFRM look an awful lot like a shell company with zero operations. The announced merger with the Integrative Stem Cell Institute is not detailed and described in any filing, yet PR hype and pumps have managed to lift the stock from $.06 to $.26 in a matter of seven sessions. The pump may be running out of breath, though, as stock price stumbled at $.27 and took a 12% tumble down to $0.23 on Friday. Promoters are calling this the usual things – a pullback, healthy consolidation and so on. This may well be the end of the fuse, despite the relatively large budget dished out to promote YFRM.
Best Penny Newsletter, one of the parties currently touting YFRM, ran a recent pump job on Livewire Ergogenics, Inc. (PINK:LVVV). Livewire’s stock is currently over 50% down from the day when Best Penny stopped promoting them.
Investors are advised to do their own research and due diligence and never trade on email advertisements, especially when the promoters are expecting to receive large sums of money for their efforts.
